Blinova Ksenia, Levine Rodney L, Boja Emily S, Griffiths Gary L, Shi Zhen-Dan, Ruddy Brian, Balaban Robert S
Laboratory of Cardiac Energetics, National Heart Lung and Blood Institute, National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892, USA.
Biochemistry. 2008 Sep 9;47(36):9636-45. doi: 10.1021/bi800307y. Epub 2008 Aug 15.
Mitochondrial NADH fluorescence has been a useful tool in evaluating mitochondrial energetics both in vitro and in vivo. Mitochondrial NADH fluorescence is enhanced several-fold in the matrix through extended fluorescence lifetimes (EFL). However, the actual binding sites responsible for NADH EFL are unknown. We tested the hypothesis that NADH binding to Complex I is a significant source of mitochondrial NADH fluorescence enhancement. To test this hypothesis, the effect of Complex I binding on NADH fluorescence efficiency was evaluated in purified protein, and in native gels of the entire porcine heart mitochondria proteome. To avoid the oxidation of NADH in these preparations, we conducted the binding experiments under anoxic conditions in a specially designed apparatus. Purified intact Complex I enhanced NADH fluorescence in native gels approximately 10-fold. However, no enhancement was detected in denatured individual Complex I subunit proteins. In the Clear and Ghost native gels of the entire mitochondrial proteome, NADH fluorescence enhancement was localized to regions where NADH oxidation occurred in the presence of oxygen. Inhibitor and mass spectroscopy studies revealed that the fluorescence enhancement was specific to Complex I proteins. No fluorescence enhancement was detected for MDH or other dehydrogenases in this assay system, at physiological mole fractions of the matrix proteins. These data suggest that NADH associated with Complex I significantly contributes to the overall mitochondrial NADH fluorescence signal and provides an explanation for the well established close correlation of mitochondrial NADH fluorescence and the metabolic state.
线粒体NADH荧光一直是评估体外和体内线粒体能量学的有用工具。通过延长荧光寿命(EFL),线粒体NADH荧光在基质中增强了几倍。然而,负责NADH EFL的实际结合位点尚不清楚。我们测试了NADH与复合体I结合是线粒体NADH荧光增强的重要来源这一假设。为了验证这一假设,在纯化的蛋白质以及整个猪心脏线粒体蛋白质组的天然凝胶中评估了复合体I结合对NADH荧光效率的影响。为了避免这些制剂中NADH的氧化,我们在一个专门设计的装置中在缺氧条件下进行了结合实验。纯化的完整复合体I在天然凝胶中使NADH荧光增强了约10倍。然而,在变性的单个复合体I亚基蛋白中未检测到增强。在整个线粒体蛋白质组的清晰和幽灵天然凝胶中,NADH荧光增强定位于有氧存在时发生NADH氧化的区域。抑制剂和质谱研究表明,荧光增强对复合体I蛋白具有特异性。在该测定系统中,在基质蛋白的生理摩尔分数下,未检测到MDH或其他脱氢酶的荧光增强。这些数据表明,与复合体I相关的NADH对整体线粒体NADH荧光信号有显著贡献,并为线粒体NADH荧光与代谢状态之间已确立的密切相关性提供了解释。